New test could better predict liver cancer treatment outcomes
NCT ID NCT01494324
Summary
This study aims to develop a better way to predict whether liver cancer ablation treatments are working. Researchers will analyze tissue samples from treated tumors to see if they can tell the difference between cancer cells and healthy cells that just look different after treatment. Current CT scans can't reliably make this distinction, which affects treatment decisions. The goal is to help doctors better monitor patients' responses to ablation therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.